Actionable news
All posts from Actionable news
Actionable news in XON: INTREXON CORP,

Intrexon: The Public Markets' Theranos Part 1 - Zika Virus Hype Is Nonsensical

Intrexon shares have rallied ~100% over the past 3 months due to hype around the company's ability to use genetically modified mosquitoes to combat the Zika virus.

Intrexon's technology has recently been questioned by high-ranking officials from the WHO, CDC and NIH.

Smart money is hitting the "eject" button and leaving retail investors holding the bag.

Today, we are rebranding Forensic Research Analyst to Spotlight Research. Note that according to a recent analysis by Bloomberg and Activist Shorts Research, Forensic Research Analyst is currently in a 3-way tie for 6th-highest campaign length returns (down 37%) along with Kyle Bass's Hayman Capital and Alpha Exposure, and one spot behind Bill Ackman's Pershing Square (down 39%).

Also today, we are publishing the first chapter of an 8-part mini-series on Intrexon (NYSE:XON), which we believe...